|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US5891472A
(en)
*
|
1996-11-19 |
1999-04-06 |
Meri Charmyne Russell |
Treatment of equine laminitis
|
|
US7629384B2
(en)
*
|
1997-09-17 |
2009-12-08 |
Strategic Science & Technologies, Llc |
Topical delivery of L-arginine to cause beneficial effects
|
|
US7914814B2
(en)
*
|
1997-09-17 |
2011-03-29 |
Strategic Science & Technologies, Llc |
Topical delivery of arginine of cause beneficial effects
|
|
US6306383B1
(en)
*
|
1998-09-16 |
2001-10-23 |
Wilson T Crandall |
Method for topical treatment of scars with protein kinase C inhibitors
|
|
JP4838936B2
(ja)
*
|
1998-10-23 |
2011-12-14 |
イデア アクチェンゲゼルシャフト |
装荷量を改善しおよび脱／会合速度を制御可能とするための、巨大分子と複合凝集体との会合体を開発し、テストし、かつ利用する方法
|
|
PT1031346E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Vacinacao nao invasiva atraves da pele
|
|
EP1031347B1
(en)
|
1999-01-27 |
2002-04-17 |
Idea Ag |
Transnasal transport/immunisation with highly adaptable carriers
|
|
MXPA02000053A
(es)
*
|
1999-07-05 |
2003-07-21 |
Idea Ag |
Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
|
|
EP1313574B1
(en)
*
|
2000-08-11 |
2008-10-29 |
WHITLOCK, David R. |
Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
|
|
JP2002136025A
(ja)
*
|
2000-10-26 |
2002-05-10 |
Mitsubishi Electric Corp |
電磁機器
|
|
US6780849B2
(en)
*
|
2000-12-21 |
2004-08-24 |
Scimed Life Systems, Inc. |
Lipid-based nitric oxide donors
|
|
US6833139B1
(en)
*
|
2002-01-09 |
2004-12-21 |
Ferndale Laboratories, Inc. |
Composition and method for the treatment of anorectal disorders
|
|
US20050244382A9
(en)
*
|
2002-01-11 |
2005-11-03 |
Whitlock David R |
Compositions including ammonia oxidizing bacteria and methods of using same
|
|
US20040018237A1
(en)
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
|
US20040092819A1
(en)
*
|
2002-08-16 |
2004-05-13 |
Hmt High Medical Technologies Ag |
Method for treating laminitis in horses, ponies and other equines with acoustic waves
|
|
US20040105881A1
(en)
*
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
US6936273B2
(en)
*
|
2002-12-20 |
2005-08-30 |
Idexx Laboratories, Inc. |
Liposomal analgesic formulation and use
|
|
BRPI0414813A
(pt)
*
|
2003-09-26 |
2006-11-14 |
David R Whitlock |
método para o uso de bactéria que oxidam a amÈnia
|
|
JP5376761B2
(ja)
*
|
2004-02-23 |
2013-12-25 |
ストラテジック サイエンス アンド テクノロジーズ， エルエルシー |
身体の外観および皮膚の外観を改善するための、一酸化窒素の局所送達
|
|
US20090105336A1
(en)
*
|
2004-04-19 |
2009-04-23 |
Strategic Science & Technologies, Llc |
Beneficial Effects of Increasing Local Blood Flow
|
|
US9226909B2
(en)
|
2004-04-19 |
2016-01-05 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
|
JP2007532697A
(ja)
*
|
2004-04-19 |
2007-11-15 |
ストラテジック サイエンス アンド テクノロジーズ， エルエルシー |
局所的血流増大の有益な効果
|
|
US20110028548A1
(en)
*
|
2004-04-19 |
2011-02-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
|
US7740875B2
(en)
*
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
KR20070086045A
(ko)
*
|
2004-11-12 |
2007-08-27 |
이데아 아게 |
피부 상태 치료에서의 확대된 표면 집합체
|
|
US7731993B2
(en)
*
|
2004-11-17 |
2010-06-08 |
Lindsey Berkson |
Composition for treating a dermal anomaly
|
|
WO2006055726A2
(en)
*
|
2004-11-17 |
2006-05-26 |
Lindsey Berkson |
Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations
|
|
WO2006128121A2
(en)
|
2005-05-27 |
2006-11-30 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
|
|
US7744928B2
(en)
*
|
2006-04-14 |
2010-06-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treatment of lesioned sites of body vessels
|
|
US7862598B2
(en)
|
2007-10-30 |
2011-01-04 |
The Invention Science Fund I, Llc |
Devices and systems that deliver nitric oxide
|
|
US7975699B2
(en)
|
2007-10-30 |
2011-07-12 |
The Invention Science Fund I, Llc |
Condoms configured to facilitate release of nitric oxide
|
|
US8221690B2
(en)
|
2007-10-30 |
2012-07-17 |
The Invention Science Fund I, Llc |
Systems and devices that utilize photolyzable nitric oxide donors
|
|
US8642093B2
(en)
|
2007-10-30 |
2014-02-04 |
The Invention Science Fund I, Llc |
Methods and systems for use of photolyzable nitric oxide donors
|
|
WO2008126088A2
(en)
*
|
2007-04-15 |
2008-10-23 |
Oron Zachar |
Anti-pyretic vasodilators
|
|
US7897399B2
(en)
|
2007-10-30 |
2011-03-01 |
The Invention Science Fund I, Llc |
Nitric oxide sensors and systems
|
|
US8980332B2
(en)
|
2007-10-30 |
2015-03-17 |
The Invention Science Fund I, Llc |
Methods and systems for use of photolyzable nitric oxide donors
|
|
US8349262B2
(en)
|
2007-10-30 |
2013-01-08 |
The Invention Science Fund I, Llc |
Nitric oxide permeable housings
|
|
US8877508B2
(en)
|
2007-10-30 |
2014-11-04 |
The Invention Science Fund I, Llc |
Devices and systems that deliver nitric oxide
|
|
US10080823B2
(en)
|
2007-10-30 |
2018-09-25 |
Gearbox Llc |
Substrates for nitric oxide releasing devices
|
|
CA2728727C
(en)
*
|
2008-06-24 |
2018-01-23 |
Intervet International B.V. |
Pharmaceutical transdermal compositions and method for treating inflammation in cattle
|
|
US20100227895A1
(en)
*
|
2009-03-05 |
2010-09-09 |
Mpco- The Magic Powder Company |
Method for treating equine laminitis
|
|
US11684624B2
(en)
|
2009-06-24 |
2023-06-27 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
|
ES2607476T3
(es)
*
|
2009-06-24 |
2017-03-31 |
Strategic Science & Technologies, Llc |
Composición tópica que contiene ibuprofeno
|
|
US9072659B2
(en)
|
2009-06-24 |
2015-07-07 |
Strategic Science & Technologies, Llc |
Topical composition containing naproxen
|
|
US12138268B2
(en)
|
2009-06-24 |
2024-11-12 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
|
EP4249001A3
(en)
|
2009-08-21 |
2023-11-29 |
Novan, Inc. |
Topical gels
|
|
DK2467173T3
(da)
|
2009-08-21 |
2019-07-29 |
Novan Inc |
Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
|
|
US8591876B2
(en)
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
|
JP2014504592A
(ja)
|
2010-12-29 |
2014-02-24 |
ストラテジック サイエンス アンド テクノロジーズ， エルエルシー |
勃起不全および他の適応症の処置
|
|
JP2014501283A
(ja)
|
2010-12-29 |
2014-01-20 |
ストラテジック サイエンス アンド テクノロジーズ， エルエルシー |
アレルギーおよび他の適応症の処置のためのシステムおよび方法
|
|
WO2012118819A2
(en)
|
2011-02-28 |
2012-09-07 |
Novan, Inc. |
Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
|
|
US8668937B2
(en)
|
2011-03-17 |
2014-03-11 |
Transdermal Biotechnology, Inc. |
Topical nitric oxide systems and methods of use thereof
|
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
|
US20160058721A1
(en)
|
2013-04-01 |
2016-03-03 |
Daiichi Sankyo Company, Limited |
Formulation for treating equine inflammation
|
|
US10517817B2
(en)
|
2013-05-09 |
2019-12-31 |
Syk Technologies, Llc |
Deep topical systemic nitric oxide therapy apparatus and method
|
|
US11225640B2
(en)
|
2014-04-15 |
2022-01-18 |
Aobiome Llc |
Ammonia oxidizing bacteria for treatment of psoriasis
|
|
CN106456678A
(zh)
|
2014-04-15 |
2017-02-22 |
Ao生物医学有限责任公司 |
氨氧化型亚硝化单胞菌菌株d23
|
|
FI3407900T3
(fi)
|
2016-01-27 |
2024-03-21 |
Syk Tech Llc |
Laitteisto typpioksidin paikalliseksi levittämiseksi ja menetelmiä
|
|
NZ753294A
(en)
*
|
2016-11-09 |
2025-11-28 |
Provita Eurotech Ltd |
Antimicrobial formulations for the improved treatment of veterinary hoof infections
|